#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14870	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2472	741.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1893	1893	T	976	T	976	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14870	16S	1529	1529	99.93	16S.l6.c30.ctg.1	2472	741.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1627	1627	C	923	C	923	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24566	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4015	762.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1959	1959	A	983	A,G	981,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24566	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4015	762.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2593	2593	C	831	C,T,A	828,1,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24566	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4015	762.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2667	2667	A	749	A	749	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24566	23S	2890	2890	99.93	23S.l15.c4.ctg.1	4015	762.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	3219	3219	C	844	C,T,G,A	841,1,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	2194	folP	852	852	99.88	folP.l15.c4.ctg.1	2088	131.0	0	.	p	.	0	E151K	NONSYN	451	453	GAA	1096	1098	AAA	225;222;219	A;A;A	225;222;219	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	2194	folP	852	852	99.88	folP.l15.c4.ctg.1	2088	131.0	1	SNP	p	R228S	1	.	.	682	684	AGC	1327	1329	AGC	212;214;212	A;G;C	212;214;212	folP.WHO_Z_01426c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4910	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3974	154.0	1	SNP	p	S91F	0	.	.	271	273	TCC	818	820	TCC	167;166;167	T;C;C	167;166;167	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4910	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3974	154.0	1	SNP	p	D95N	0	.	.	283	285	GAC	830	832	GAC	163;165;166	G;A,T;C	163;164,1;166	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4910	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3974	154.0	1	SNP	p	D95G	0	.	.	283	285	GAC	830	832	GAC	163;165;166	G;A,T;C	163;164,1;166	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	2026	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1766	143.2	1	SNP	p	G45D	0	.	.	133	135	GGC	708	710	GGC	229;228;230	G,A;G;C	228,1;228;230	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1046	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1572	83.1	0	.	n	.	0	A197.	DEL	197	197	A	836	836	A	208	A	208	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4840	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3425	176.3	1	SNP	p	D86N	0	.	.	256	258	GAC	833	835	GAC	208;205;206	G;A,C;C	208;204,1;206	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4840	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3425	176.3	1	SNP	p	S87W	0	.	.	259	261	AGT	836	838	AGT	206;207;207	A;G;T	206;207;207	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4840	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3425	176.3	1	SNP	p	S87I	0	.	.	259	261	AGT	836	838	AGT	206;207;207	A;G;T	206;207;207	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4840	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3425	176.3	1	SNP	p	S87R	0	.	.	259	261	AGT	836	838	AGT	206;207;207	A;G;T	206;207;207	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	4840	parC	2304	2304	99.91	parC.l15.c4.ctg.1	3425	176.3	1	SNP	p	S88P	0	.	.	262	264	TCC	839	841	TCC	207;208;210	T;C,A;C	207;206,2;210	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4336	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3014	179.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1715	1717	GGC	226;223;223	G;G;C	226;223;223	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4134	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2792	184.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1499	1501	GCA	249;248;249	G,A;C,A;A,G	248,1;247,1;248,1	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4134	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2792	184.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1502	1504	ATC	249;249;248	A;T;C,A	249;249;247,1	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4134	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2792	184.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1514	1516	GTG	239;241;245	G,T;T,G;G	238,1;240,1;245	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4134	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2792	184.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1514	1516	GTG	239;241;245	G,T;T,G;G	238,1;240,1;245	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4134	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2792	184.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2018	2020	ACC	220;222;222	A,C;C;C,A	219,1;222;221,1	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4134	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2792	184.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2072	2074	GCG	208;204;207	G;C,G,A;G	208;202,1,1;207	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4134	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2792	184.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2072	2074	GCG	208;204;207	G;C,G,A;G	208;202,1,1;207	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4134	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2792	184.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2195	2197	GGC	243;243;243	G,A,C;G;C	241,1,1;243;243	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4134	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2792	184.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2204	2206	GGC	241;243;242	G,T,C;G;C	239,1,1;243;242	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4134	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2792	184.4	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2222	2224	CTG	253;251;249	C,A;T,A;G,T,A	251,2;249,2;247,1,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5946	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3554	208.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1868	1870	CCG	278;280;281	C,T;C;G,A	277,1;280;280,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2564	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2286	139.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	837	837	C	188	C,A	187,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	100	94.0	porB1a.l15.c4.ctg.2	182	57.0	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	68;63;61	A;C;G	68;63;61	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	100	94.0	porB1a.l15.c4.ctg.2	182	57.0	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	24;20;15	C;A;A	24;20;15	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c4.ctg.4	391	35.5	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	25;25;26	T;T;A	25;25;26	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c4.ctg.4	391	35.5	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	74;74;74	C;A;T	74;74;74	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c4.ctg.4	391	35.5	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	74;74;74	A;G;T	74;74;74	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c4.ctg.4	391	35.5	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	74;74;74	T;A;C	74;74;74	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c4.ctg.4	391	35.5	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c4.ctg.4	391	35.5	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c4.ctg.4	391	35.5	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	1;1;1	G;A;C	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c4.ctg.4	391	35.5	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	1;1;1	A;T;C	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c4.ctg.4	391	35.5	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	1;1;1	T;C;G	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c4.ctg.4	391	35.5	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	1;1;1	G;C;C	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c4.ctg.4	391	35.5	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	1;1;3	A;G;C	1;1;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c4.ctg.4	391	35.5	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	3;3;3	G;C;C	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	330	porB1a	984	226	90.27	porB1a.l15.c4.ctg.4	391	35.5	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	3;3;3	G;T;T	3;3;3	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1598	224.4	0	.	p	.	0	N38E	NONSYN	112	114	AAT	519	521	GAA	266;264;263	G;A;A	266;264;263	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1598	224.4	0	.	p	.	0	E48K	NONSYN	142	144	GAA	549	551	AAA	261;268;271	A;A;A	261;268;271	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1598	224.4	0	.	p	.	0	N134D	NONSYN	400	402	AAT	807	809	GAT	258;256;258	G,T;A;T,C	256,2;256;257,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1598	224.4	0	.	p	.	0	P175S	NONSYN	523	525	CCA	930	932	TCA	288;288;287	T;C;A	288;288;287	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1598	224.4	0	.	p	.	0	A218I	NONSYN	652	654	GCC	1059	1061	ATC	271;270;272	A;TCCCC,TCC;C,A	271;264,1;271,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1598	224.4	0	.	p	.	0	G255R	NONSYN	763	765	GGA	1170	1172	AGA	235;233;235	A;G;A	235;233;235	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1598	224.4	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1389	1391	GCA	247;247;249	G;C;A,T	247;247;248,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1598	224.4	1	SNP	p	G120K	1	.	.	358	360	AAG	765	767	AAG	263;265;265	A;A;G,T,A	263;265;263,1,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1598	224.4	1	SNP	p	D121N	0	.	.	361	363	GAC	768	770	GAC	269;270;268	G;A,C;C	269;269,1;268	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2972	porB1b	1047	1047	99.04	porB1b.l15.c30.ctg.1	1598	224.4	1	SNP	p	A121D	1	.	.	361	363	GAC	768	770	GAC	269;270;268	G;A,C;C	269;269,1;268	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10010	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5197	239.9	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2132	2134	AAT	280;281;280	A;A,C;T,C	280;280,1;279,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1542	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1535	125.3	1	SNP	p	V57M	1	.	.	169	171	ATG	747	749	ATG	289;287;286	A;T,G;G	289;285,2;286	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
